Scientists at the Walter and Eliza Hall Institute and their collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients.
The development of the compound, called WEHI-539, is an important step towards the design of a potential new anti-cancer agent. WEHI-539 has been designed to bind and block the function of a protein called BCL-XL that normally prevents cells from dying. The death and elimination of abnormal cells in the body is an important safeguard against cancer development. But cancer cells often acquire genetic changes that allow them to bypass cell death, which also reduces the effectiveness of anti-cancer treatments such as chemotherapy.
Cancer cells can become long-lived by producing high levels of BCL-XL protein, and high levels of BCL-XL are also associated with poorer outcomes for patients with lung, stomach, colon and pancreatic cancer.
Dr Guillaume Lessene, Professor Keith Watson and Professor David Huang from the institute's ACRF Chemical Biology division, and Dr Peter Czabotar and Professor Peter Colman from the institute's Structural Biology division led the development of WEHI-539 in collaboration with colleagues at Genentech, a member of the Roche group. The research is published online today in the journal Nature Chemical Biology.
Dr Lessene said the development of WEHI-539 was an important milestone on the way to creating potential anti-cancer agents that act to restore cell death by inhibiting BCL-XL. "Although WEHI-539 is not optimised for use in patients, it will be a very valuable tool for researchers to use to dissect how BCL-XL controls cancer cell survival," he said.
WEHI-539 belongs to a class of chemicals called 'BH3-mimetics', which all bind to the same region of BCL-XL or related proteins. Two BH3-mimetics, called navitoclax (ABT-263) and ABT-199/GDC-0199 are currently in clinical trials for the treatment of cancer, particularly those of the blood and lymph glands (leukaemia and lymphoma).
Dr Lessene said WEHI-539 was the product of a sustained research program. "We were very excited to see the team's work culminate in a compound that specifically inhibits BCL-XL," he said. "WEHI-539 is the first compound that our chemists have developed from scratch, using the three-dimensional structure of BCL-XL to build and refine its design."
Explore further: New pill holds promise for fewer side effects in treating leukemia
More information: Paper: DOI: 10.1038/nchembio.1246
6 hours ago If we add br2 / hv to (s)-1,2-dibromobutane. Where would the radical bromine go? The book hints that the product is an optically inactive substance.... 19 hours ago Hi guys, I'm having a bit of difficulty understanding Pourboix diagrams. The biggest problem at the moment is that I don't clearly understand what... 20 hours ago Hi to all, I want to know the temperature after combustion of methane with air. How will i calculate it? Kindly inform me. Regards,... Apr 28, 2013 I am familiar with the equation ?G=?G°+RT ln(Q).But I can't derive it.We have to use the equation to derive nernst equation. So please help. Apr 28, 2013 Hi, can someone please explain to me how I can identify which is the oxidation half and which is the reduction half of a redox reaction. I have read... Apr 27, 2013 I have been urinating into a plastic bottle lately (I will not elaborate why), and have been finding the bottle to hold a vacuum the following... Jul 18, 2011 Some of the most aggressive forms of breast cancer are more vulnerable to chemotherapy when it is combined with a new class of anti-cancer agent, researchers from the Walter and Eliza Hall Institute have shown.
Jan 07, 2013 (Medical Xpress)—An international team of researchers has developed a new anti-cancer drug that holds promise as a therapy that fights cancer while causing fewer side effects than current medicines. The ...
Sep 14, 2009 In blood cells, the protein Bcl-xL has a well-characterized role in preventing cell death by a process known as apoptosis. However, its function(s) in osteoclasts, cells that slowly breakdown bone (a process known as resorption), ...
Apr 16, 2009 A protein called Mcl-1 plays a critical role in melanoma cell resistance to a form of apoptosis called anoikis, according to research published this week in Molecular Cancer Research.
16 hours ago (Phys.org) —While the natural world is replete with compounds that form the basis of many disease-fighting pharmaceuticals, it is also the case that humans and other mammals produce their own host-defense ...
21 hours ago (Phys.org) —There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause ...
Apr 29, 2013 (Phys.org) —A combined team of researchers from the U.S. and Slovenia has succeeded in creating "origami" type proteins that assemble themselves into three dimensional shapes. As a proof of concept, the ...
Apr 25, 2013 (Phys.org) —Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new ...
New research at MIT could dramatically improve the efficiency of fuel cells, which are considered a promising alternative to batteries for powering everything from electronic devices to cars and homes.
(Phys.org) —While the natural world is replete with compounds that form the basis of many disease-fighting pharmaceuticals, it is also the case that humans and other mammals produce their own host-defense ...
(Phys.org) —In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens ...
(Phys.org) —There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause ...
From methanol to formaldehyde - this reaction is the starting point for the synthesis of many everyday plastics. Using catalysts made of gold particles, formaldehyde could be produced without the environmentally ...
Just as people have embraced computers and smart phones, they may also give their blessing to talking tissue boxes and other smart objects, according to Penn State researchers.
Although eleventh-century Vikings did not have magnetic compasses at their disposal, it is thought that they could determine their orientation at sea using sun-compasses. Sun-compasses use the position of ...
A tiny bird fossil discovered in Wyoming offers clues to the precursors of swift and hummingbird wings. The fossil is unusual in having exceptionally well-preserved feathers, which allowed the researchers ...
A new study by researchers in the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital examined injuries to children related to amusement rides, which included ...
Elderly patients who receive anesthesia are no more likely to develop long-term dementia or Alzheimer's disease than other seniors, according to new Mayo Clinic research. The study analyzed thousands of patients using the ...
© Phys.org™ 2003-2013var _comscore = _comscore || [];var csDocDomain = document.location.href; _comscore.push({ c1: "2", c2: "6035753", c3: "6035753", c4: csDocDomain }); (function() { var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true; s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js"; el.parentNode.insertBefore(s, el);})();
No comments:
Post a Comment